Platinum group metal (PGM) complexes having acylthiourea ligand system as catalysts or anticancer agents

S Swaminathan, P Jerome, RJ Deepak… - Coordination Chemistry …, 2024 - Elsevier
The intention behind the design of a metal complex is quite crucial for its development
towards a particular application. Transition metal complexes have tremendously become …

Complexes of ruthenium (II) as promising dual-active agents against cancer and viral infections

A D'Amato, A Mariconda, D Iacopetta, J Ceramella… - Pharmaceuticals, 2023 - mdpi.com
Poor responses to medical care and the failure of pharmacological treatment for many high-
frequency diseases, such as cancer and viral infections, have been widely documented. In …

Half-Sandwich Iridium(III), Rhodium(III), and Ruthenium(II) Complexes Chelating Hybrid sp2-N/sp3-N Donor Ligands to Achieve Improved Anticancer Selectivity

L Guo, P Li, J Li, Y Gong, X Li, Y Liu, K Yu… - Inorganic …, 2023 - ACS Publications
The biological efficacy of half-sandwich platinum group organometallic complexes of the
formula [(η5-Cpx)/(η6-arene) M (XY) Cl] 0/+(XY= bidentate ligands; Cpx= functionalized …

Mucin-Triggered Osmium Nanoclusters as Protein-Corona-Like Nanozymes with Photothermal-Enhanced Peroxidase-Like Activity for Tumor-Specific Therapy

S He, Q Zheng, L Ma, H Shen, B Zheng, Y Zhang… - Nano Letters, 2024 - ACS Publications
Nanomaterials with peroxidase-like activity and photothermal conversion efficiency have
garnered significant attention for their ability to generate cytotoxic hydroxyl radicals and …

From Concept to Cure: The Road Ahead for Ruthenium‐Based Anticancer Drugs

S Swaminathan, J Haribabu, R Karvembu - ChemMedChem, 2024 - Wiley Online Library
The evolution of chemotherapy, especially the dawn of metal‐based drugs, represents a
transformative era in cancer treatment. From the serendipitous discovery of mustard gas's …

Ruthenium (ii)–Arene Complex Triggers Immunogenic Ferroptosis for Reversing Drug Resistance

M Lv, Y Zheng, X Dai, J Zhao, G Hu… - Journal of Medicinal …, 2024 - ACS Publications
Chemoresistance remains an arduous challenge in oncology, but ferroptosis shows
potential for overcoming it by stimulating the immune system. Herein, a novel high …

Triphenylphosphine-Modified IridiumIII, RhodiumIII, and RutheniumII Complexes to Achieve Enhanced Anticancer Selectivity by Targeting Mitochondria

Z Liu, H Fu, H Dong, K Lai, Z Yang, C Fan… - Inorganic …, 2024 - ACS Publications
The incorporation of an organelle-targeting moiety into compounds has proven to be an
effective strategy in the development of targeted anticancer drugs. We herein report the …

Design, synthesis and anticancer evaluation of novel half-sandwich Ru (II) complexes bearing pyrazalone moiety: Apoptosis inducers based on mitochondrial …

Y Huang, S Huang, W Wei, Y Wu, L Jia, Y Du… - Journal of Inorganic …, 2024 - Elsevier
Six half-sandwich Ru (II) complexes (Ru1-Ru6), integrated with 5-phenyl-2-(pyridin-2-yl)-2, 4-
dihydro-3H-pyrazol-3-one (PDPO1-PDPO6) ligands, were synthesized and …

Green Light-Triggered Photocatalytic Anticancer Activity of Terpyridine-Based Ru (II) Photocatalysts

AA Mandal, V Singh, S Saha, S Peters… - Inorganic …, 2024 - ACS Publications
The relentless increase in drug resistance of platinum-based chemotherapeutics has
opened the scope for other new cancer therapies with novel mechanisms of action (MoA) …

Triphenylphosphine-modified cyclometalated iridiumIII complexes as mitochondria-targeting anticancer agents with enhanced selectivity

H Fu, S Wang, Y Gong, H Dong, K Lai, Z Yang… - Bioorganic …, 2025 - Elsevier
This study presents the development and evaluation of triphenylphosphine-modified
cyclometalated iridium III complexes as selective anticancer agents targeting mitochondria …